Form 8-K - Current report:
SEC Accession No. 0001558370-25-004491
Filing Date
2025-04-04
Accepted
2025-04-04 17:11:36
Documents
14
Period of Report
2025-04-03
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

Document Format Files

Seq Description Document Type Size
1 8-K elev-20250403x8k.htm   iXBRL 8-K 48381
  Complete submission text file 0001558370-25-004491.txt   181054

Data Files

Seq Description Document Type Size
2 EX-101.SCH elev-20250403.xsd EX-101.SCH 4017
3 EX-101.DEF elev-20250403_def.xml EX-101.DEF 2818
4 EX-101.LAB elev-20250403_lab.xml EX-101.LAB 17914
5 EX-101.PRE elev-20250403_pre.xml EX-101.PRE 11882
16 EXTRACTED XBRL INSTANCE DOCUMENT elev-20250403x8k_htm.xml XML 4998
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

EIN.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40523 | Film No.: 25815730
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)